Most recently added articles listed first
Comment by Dr Mark Lavercombe:
In an attempt to demonstrate an association between diabetes mellitus and lung function, this community cohort of 6,483 middle-aged and older adults in Korea underwent serial lung function testing over sixteen years. At baseline, participants with diabetes had significantly lower FEV1, FEV1 % predicted, FVC, FVC % predicted, and FEV1/FVC, even after adjustment for covariates (age, sex, height, body mass index, waist circumference, smoking status, exercise status, and education level). Longitudinal analysis shows a higher rate of decline in those with diabetes compared with those with normoglycaemia. This study strengthens the argument for an association between impaired glycaemic control and impaired lung function.
Comment by Dr Mark Lavercombe:
Supranormal spirometry values in an individual patient are of uncertain significance. In this report, authors evaluate an Austrian general population cohort to identify the prevalence of supranormal forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). Multivariate regression analysis demonstrates that female sex, higher muscle mass, less diabetes, and fewer respiratory symptoms were all associated with supranormal spirometry results. Supranormal spirometry was associated with higher static lung volumes and lower specific airway resistance.
Comment by Dr Mark Lavercombe:
It is known that having Chronic Obstructive Pulmonary Disease results in increased energy expenditure, and that both weight loss and muscle loss are associated with poorer outcomes. In this study, the authors assessed annual body composition changes using computed tomography in a cohort of patients with COPD or at risk for COPD. Participants experienced an annual loss of weight and height, with no change in their body mass index, while decreased muscle mass and increased fat mass were noted over time. Muscle loss was most obvious in those with reduced lung function.
Comment by Dr Mark Lavercombe:
Although reporting of bronchoprovocation testing relies heavily on a change in FEV1 following exposure to the provoking agent, it is plausible that other lung function parameters might provide additional information in the assessment of airway hyperresponsiveness (AHR). In this study, the authors performed lung volume estimation using body plethysmography as part of their protocol for methacholine challenge testing. They demonstrate that specific airway conductance (sGaw) is reduced in a substantial number of patients that did not achieve a reduction of 20% in FEV1, and suggest that incorporation of sGaw leads to a higher sensitivity for AHR.
Comment by Dr Mark Lavercombe:
Although reporting of bronchoprovocation testing relies heavily on a change in FEV1 following exposure to the provoking agent, it is plausible that other lung function parameters might provide additional information in the assessment of airway hyperresponsiveness (AHR). In this study, the authors performed lung volume estimation using body plethysmography as part of their protocol for methacholine challenge testing. They demonstrate that specific airway conductance (sGaw) is reduced in a substantial number of patients that did not achieve a reduction of 20% in FEV1, and suggest that incorporation of sGaw leads to a higher sensitivity for AHR.
Comment by Dr Mark Lavercombe:
This fascinating paper reports the result of bedside ultrasonographic evaluation of both ipsilateral and contralateral diaphragmatic function in patients presenting with unilateral pleural effusion, before and after pleurocentesis. Contralateral hemidiaphragmatic excursion increased in inverse proportion to ipsilateral hemidiaphragmatic excursion, with subsequent normalisation on both sides after drainage. Improvement in ipsilateral excursion correlated with improvement in dyspnoea. These novel findings suggest the need for further study of ventilatory drive and the mechanics of both hemidiaphragms in the setting of pleural effusion, and their association with dyspnoea.
Comment by Dr Mark Lavercombe:
The authors of this paper illustrate the use of the forced oscillation technique to evaluate lung mechanics in people exposed to PM2.5 particulate matter after a fire in an open-cut brown coal mine in Hazelwood, Australia. Comparison with local residents who were not exposed to the same air pollution demonstrates more negative respiratory system reactance.
Comment by Dr Mark Lavercombe:
The rapid escalation in 'vaping' using electronic nicotine delivery devices has not yet been matched by data demonstrating their safety. In a cohort of asthmatic patients taking regular inhaled corticosteroids, acute markers of airway inflammation and pulmonary function changed within five minutes of e-cigarette vaping and this did not occur in healthy controls. The authors discuss the implications for future research in both healthy subjects and patients with pre-existing obstructive lung diseases.
Comment by Dr Mark Lavercombe:
In this study the authors demonstrate associations between sputum bacterial community characteristics and both structural and clinical measures in patients with bronchiectasis. Increase in blood inflammatory markers levels correlated with lower bacterial diversity, while reduced bacterial diversity, richness and evenness were associated with structural abnormalities on HRCT. The authors suggest a potential role for pathogenic bacterial dominance contributing to disease state.
Comment by Dr Mark Lavercombe:
This study evaluates the effect of high-intensity inspiratory muscle training in patients with non-cystic fibrosis bronchiectasis. Two of the three weekly sessions were performed in the patients' homes using a threshold loading device. Improvements in shuttle walk distance and respiratory muscle strength and endurance are noted, along with the social dimension of quality of life. Treatment was well tolerated.
Comment by Dr Mark Lavercombe:
Clinicians have long relied on extrapolation of data from COPD studies to inform decision making around oxygen supplementation in patients with other chronic lung diseases. This study demonstrates a difference between patients with fibrotic ILDs and COPD in the degree of exertional oxygen desaturation, raising important questions about the appropriateness of extrapolation.
Comment by Dr Mark Lavercombe:
The authors of this paper describe the immediate effects of e-cigarette inhalation in mild asthmatic patients and healthy smokers. Using impulse oscillometry and fractional exhaled nitric oxide levels they demonstrate immediate effects which persisted longer in the asthmatic patients.
Comment by Dr Mark Lavercombe:
The authors of this paper describe the distinct pathology, physiology and radiology findings in a cohort of patients with biomass smoke exposure associated COPD compared with COPD related to cigarette smoking. They provide evidence of a distinct COPD phenotype that warrants further study.
Comment by Dr Mark Lavercombe:
The authors of this paper describe a cohort of patients with COPD who were stratified based on self-report of prior history of tuberculosis infection. Patients who admitted to prior Tb had more severe symptoms of COPD, poorer lung function and more frequent exacerbations. This difference was noted despite a lower prevalence of ongoing smoking in the tuberculosis group.
Comment by Dr Mark Lavercombe:
Vocal cord dysfunction is not uncommon in patients after lung cancer resection, and this study demonstrates a significant association with poor post-operative outcomes including pneumonia, need for bronchoscopy and re-intubation. The authors recommend routine laryngeal screening within 24h of surgery, although treatment outcomes were not assessed in this study.
Comment by Dr Mark Lavercombe:
Using data from the China National Health Survey 2012–2015, the authors of this paper propose spirometry prediction equations for a general Chinese population aged 7–80 years. Their equations compare favourably to those developed in more heterogeneous cohorts.
Comment by Dr Mark Lavercombe:
The PA:A ratio as measured on chest CT scan has been demonstrated to predict pulmonary hypertension in some studies. In this cohort PA:A > 0.9 is found to predict both elevated mPAP and survival in patients with idiopathic pulmonary fibrosis.
Despite the clear health benefits in COPD patients, participation in pulmonary rehabilitation is variable with potential barriers including reduced mobility, lack of transport or travel costs. This randomised controlled trial evaluates home-based telerehabilitation compared with usual care and finds improved endurance exercise capacity and self-efficacy in the treatment group. Telerehabilitation might be an alternative option for pulmonary rehabilitation in those unable to attend centralised programmes. Table 3 presents outcomes for special consideration.
Prognosis in patients with fibrotic interstitial lung diseases can vary significantly. In this study, the authors demonstrate that Frailty is highly prevalent in a cohort of patients with fibrotic ILD and strongly associated with dyspnoea severity. The authors propose a potential role for frailty assessment in identifying patients at risk of complications from invasive procedures or medical therapies, and/or mortality.
Pulmonary Rehabilitation Guidelines for Australia and New Zealand Jennifer A Alison, Zoe J McKeough, Kylie Johnston, Renae J McNamara, Lissa M Spencer, Sue C Jenkins, Catherine J Hill, Vanessa M McDonald, Peter Frith, Paul Cafarella, Michelle Brooke, Helen L Cameron-Tucker, Sarah Candy, Nola Cecins, Andrew S L Chan, Marita T Dale, Leona M Dowman, Catherine Granger, Simon Halloran, Peter Jung, Annemarie L Lee, Regina Leung, Tamara Matulick, Christian Osadnik, Mary Roberts, James Walsh, Sally Wootton, Anne E Holland, on behalf of the Lung Foundation Australia and the Thoracic Society of Australia and New Zealand 10.1111/resp.13025 (Apr 2017)
The aim of these Guidelines is to provide evidence-based recommendations for the practice of pulmonary rehabilitation (PR) specific to Australian and New Zealand healthcare contexts.
These first-ever pulmonary rehabilitation Guidelines for Australia and New Zealand were launched (24-28 March 2017) at the TSANZSRS Annual Scientific Meeting in Canberra, Australia (24-28 March 2017), and were drawn up following a systematic review of over 275 clinical trials.
The Guidelines recommend that all COPD patients should be offered pulmonary rehabilitation regardless of their disease severity.
See the full Editorial for these important Guidelines at onlinelibrary.wiley.com/doi/10.1111/resp.13039/full
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report Claus F Vogelmeier, Gerard J Criner, Fernando J Martinez, Antonio Anzueto, Peter J Barnes, Jean Bourbeau, Bartolome R Celli, Rongchang Chen, Marc Decramer, Leonardo M Fabbri, Peter Frith, David M G Halpin, M Victorina López Varela, Masaharu Nishimura, Nicolas Roche, Roberto Rodriguez-Roisin, Don D Sin, Dave Singh, Robert Stockley, Jørgen Vestbo, Jadwiga A Wedzicha and Alvar Agusti 10.1111/resp.13012 (Apr 2017)
This Executive Summary focuses primarily on the revised and novel parts of the document, including:
Comment by Dr Mark Lavercombe:
This study examines the utility of bronchoscopy in patients admitted with acute exacerbations of interstitial lung disease. Although a relatively low diagnostic yield is identified, significant potential complications are noted and there is no in-hospital mortality benefit seen in those undergoing the procedure.
Comment by Dr Mark Lavercombe:
This study identifies important risk factors for mortality in Asian patients with COPD, and develops a prognosis model that is easy to use. Further validation studies will be required to assess its utility.
Comment by Dr Mark Lavercombe:
This paper describes the experience of managing a very rare complication of endotracheal intubation or tracheostomy, including the nature and anatomical distribution of the injuries. Finally, outcomes using different treatment approaches is discussed.
Insulin resistance is associated with skeletal muscle weakness in COPD. Wells et al.
onlinelibrary.wiley.com/doi/10.1111/resp.12716/abstract (Dec 2015)
Differences in baseline factors and survival between normocapnia, compensated respiratory acidosis and decompensated respiratory acidosis in COPD exacerbation: A pilot study. Lun et al.
onlinelibrary.wiley.com/doi/10.1111/resp.12652/abstract (Oct 2015)
Efficacy and tolerability of budesonide/formoterol added to tiotropium compared with tiotropium alone in patients with severe or very severe COPD: A randomized, multicentre study in East Asia. Lee et al.
onlinelibrary.wiley.com/doi/10.1111/resp.12646/abstract (Sep 2015)
Mother's smoking and complex lung function of offspring in middle age: A cohort study from childhood. Perret et al.
onlinelibrary.wiley.com/doi/10.1111/resp.12750/abstract (Mar 2016)
(FREE access: Editor's Choice)
Effect of long-term treatment with corticosteroids on skeletal muscle strength, functional exercise capacity and health status in patients with interstitial lung disease. Hanada et al.
onlinelibrary.wiley.com/doi/10.1111/resp.12807/abstract (May 2016)
(FREE access: Editor's Choice; Editorial: onlinelibrary.wiley.com/doi/10.1111/resp.12843/abstract)